NICE has been notified about this procedure and will consider it as part of its work programme. The Interventional Procedures Advisory Committee (IPAC) will consider this procedure and NICE will issue an interventional procedures consultation document about its safety and efficacy for 4 weeks’ public consultation. IPAC will then review the consultation document in the light of comments received and produce a final interventional procedures document, which will be considered by NICE before guidance is issued to the NHS in England, Wales, Scotland and Northern Ireland.
Status In progress
Process IP
ID number 1563
Description Intranasal phototherapy involves using a device with light-emitting probes, which are inserted into the nasal cavity for several minutes at a time. Some devices are designed to be self-administered, whereas others are administered by a clinician. There are different devices available and the duration and dose of treatment varies. The devices use different frequencies of light, ranging from ultraviolet to infrared. Intranasal phototherapy is claimed to increase local blood flow and suppress inflammation. The aim is to reduce the symptoms of allergic rhinitis.


Key events during the development of the guidance:

Date Update
22 February 2018 - 22 March 2018 Interventional procedure consultation

For further information on how we develop guidance, please see our page about NICE interventional procedures guidance